Hospital Readmissions Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Arformoterol or Fluticasone/Salmeterol

被引：0
|
作者：
Stensland, Mike [1 ]
Bollu, Vamsi [1 ]
Donohue, James [1 ]
机构：
[1] Agile Outcomes Res Inc, Rochester, MN USA
来源：
CHEST | 2015年 / 148卷 / 04期
关键词：
D O I：
10.1378/chest.2278614
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
716A
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hospital Readmissions Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Arformoterol or Tiotropium
    Stensland, Mike
    Bollu, Vamsi
    Donohue, James
    CHEST, 2015, 148 (04)
  • [2] Chronic obstructive Pulmonary Disease Importance of Salmeterol and Fluticasone for Survival
    Hamm, H.
    PNEUMOLOGE, 2007, 4 (05): : 351 - 352
  • [3] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08): : 775 - 789
  • [4] Predictors of Pulmonary Function Response to Treatment with Salmeterol/fluticasone in Patients with Chronic Obstructive Pulmonary Disease
    Lee, Jae Seung
    Huh, Jin Won
    Chae, Eun Jin
    Seo, Joon Beom
    Ra, Seung Won
    Lee, Ji-Hyun
    Kim, Eun-Kyung
    Lee, Young Kyung
    Kim, Tae-Hyung
    Kim, Woo Jin
    Lee, Jin Hwa
    Lee, Sang-Min
    Lee, Sangyeub
    Lim, Seong Yong
    Shin, Tae Rim
    Yoon, Ho Il
    Sheen, Seung Soo
    Oh, Yeon-Mok
    Lee, Sang-Do
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (03) : 379 - 385
  • [5] AN ECONOMIC EVALUATION OF INDACATEROL/GLYCOPYRRONIUM COMPARED WITH TIOTROPIUM AND SALMETEROL/FLUTICASONE FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THAILAND
    Boonsawat, W.
    Geater, S. L.
    Burke, C.
    Numuang, K.
    RESPIROLOGY, 2016, 21 : 180 - 180
  • [6] Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
    Halpern, Rachel
    Baker, Christine L.
    Su, Jun
    Woodruff, Kimberly B.
    Paulose-Ram, Ryne
    Porter, Victoria
    Shah, Hemal
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 375 - 388
  • [7] Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease
    Dransfield, MT
    Bailey, WC
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1815 - 1826
  • [8] An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
    Boyd, G
    Morice, AH
    Pounsford, JC
    Siebert, M
    Peslis, N
    Crawford, C
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (04) : 815 - 821
  • [9] Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
    Kardos, Peter
    Wencker, Marion
    Glaab, Thomas
    Vogelmeier, Claus
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (02) : 144 - 149
  • [10] Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
    Yasui, Hideki
    Inui, Naoki
    Fujisawa, Tomoyuki
    Karayama, Masato
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Ohba, Hisano
    Yokomura, Koshi
    Sato, Jun
    Sato, Masaki
    Koshimizu, Naoki
    Toyoshima, Mikio
    Yamada, Takashi
    Masuda, Masafumi
    Shirai, Toshihiro
    Suda, Takafumi
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2018, 12
12345